Recombinant Human HMGB1, CF

Images

 

Product Details

Summary
Product Discontinued
View other related HMGB1/HMG-1 Peptides and Proteins

Order Details


    • Catalog Number
      1690-HM
    • Availability
      Product Discontinued

    Can't find what you are looking for? Use our Antibody Concierge Service & we will help you locate your antibody!

    Or feel free to contact us for alternative products.

Recombinant Human HMGB1, CF Summary

Details of Functionality
Measured in a competitive binding assay. When recombinant human RAGE Fc Chimera is immobilized at 2 µg/mL (100 µL/well), Recombinant Human HMGB1/HMG‑1 inhibits 50% binding of biotinylated recombinant human HMGB1 (0.25 µg/mL) at the concentration range of 0.35-1.4 µg/mL.
Source
Mouse myeloma cell line, NS0-derived human HMGB1/HMG-1 protein
Met1-Glu215
Accession # P09429.3
Accession #
Protein/Peptide Type
Recombinant Proteins
Purity
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain
Endotoxin Note
<0.10 EU per 1 μg of the protein by the LAL method.

Applications/Dilutions

Dilutions
  • Binding Activity
Theoretical MW
24.9 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
SDS-PAGE
30-36 kDa, reducing conditions
Publications
Read Publications using
1690-HM in the following applications:

Packaging, Storage & Formulations

Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after opening.
  • 3 months, -20 to -70 °C under sterile conditions after opening.
Buffer
Supplied as a 0.2 μm filtered solution in PBS, EDTA and DTT.
Purity
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain
Reconstitution Instructions

It is recommended that sterile PBS be added to the vial to prepare a working stock solution of no less than 100 μg/mL. The carrier-free protein should be used immediately upon reconstitution to avoid losses in activity due to non-specific binding to the inside surface of the vial. For long term storage as a dilute solution, a carrier protein (e.g. 0.1% HSA or BSA) should be added to the vial.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Recombinant Human HMGB1, CF

  • Amphoterin
  • high mobility group box 1
  • High mobility group protein 1
  • high mobility group protein B1
  • high-mobility group (nonhistone chromosomal) protein 1
  • high-mobility group box 1
  • HMG1
  • HMG-1
  • HMG1DKFZp686A04236
  • HMG3
  • HMGB1
  • SBP-1
  • Sulfoglucuronyl carbohydrate binding protein

Background

High-mobility Group Box 1 protein (HMGB1), also known as HMG1 or Amphoterin, is a member of the high mobility group box family of non-histone chromosomal proteins (1-3). Human HMGB1 is expressed as a 25 kDa single chain protein containing two globular positively charged DNA-binding domains (HMG boxes A and B) and a negatively charged C-terminal region that contains only Asp and Glu residues (4, 5). Posttranslational modification of HMBG1, including acetylation, phosphorylation, and methylation, affects HMBG1 localization, receptor interactions, and bioactivity (3). An intramolecular disulfide bond between Cys23 and Cys45 as well as the presence of the unpaired Cys106 thiol are critical for HMGB1-induced pro-inflammatory TNF-alpha secretion (2, 6). Alternatively, fully reduced HMGB1 acts as a potent chemoattractant for neutrophils and monocytes (7). HMGB1 can be localized to the nucleus or cytoplasm and can also be secreted despite its lack of a signal peptide (2). HMGB1 binds DNA in a non-sequence specific manner and may act as a structural cofactor during gene transcription (8). Acetylation of HMGB1 results in its cytoplasmic localization and eventual secretion (9). HMGB1 can be secreted by multiple cell types, and it is also released upon cell necrosis, apoptosis, and pyroptosis (2, 3). HMBG1 is widely recognized as a multifunctional alarmin that stimulates inflammation upon sterile or infectious insult. Receptors for HMGB1 include TLR2, TLR4, TLR9, Syndecan-3, Siglec-10, Integrin alpha M beta 2, CXCR4, TIM-3, and RAGE (1, 2). It is implicated in the pathogenesis of a broad range of diseases including atherosclerosis, sepsis, cancer, neurodegenerative diseases, and autoimmunity (3, 10-13).
  1. Yanai, H. et al. (2012) Trends Immunol. 33:633.
  2. Yang, H. et al. (2013) J. Leukoc. Biol. 93:865.
  3. Harris, H.E. et al. (2012) Nat. Rev. Rheumatol. 8:195.
  4. Degryse, B. and M. de Virgilio (2003) FEBS Lett. 553:11.
  5. Wen, L. et al. (1989) Nucleic Acids Res. 17:1197.
  6. Yang, H. et al. (2012) Mol. Med. 18:250.
  7. Venereau, E. et al. (2012) J. Exp. Med. 209:1519.
  8. Bianchi, M.E. and A. Agresti (2005) Curr. Opin. Genet. Dev. 15:496.
  9. Bonaldi, T. et al. (2003) EMBO J. 22:5551.
  10. Diener, K.R. et al. (2013) Immunol. Cell Biol. 91:443.
  11. Fang, P. et al. (2012) Mol. Neurobiol. 45:499.
  12. de Souza, A.W. et al. (2012) Autoimmun. Rev. 11:909.
  13. Bae, J.S. (2012) Arch. Pharm. Res. 35:1511.

Customers Who Viewed This Item Also Viewed...

NB100-56566
Species: Bv, Hu, Ma, Mu, Po, Rt
Applications: B/N, ChIP, CyTOF-ready, DB, Dual ISH-IHC, ELISA(Cap), ELISA, Flow-CS, Flow-IC, Flow, ICC/IF, IHC, IHC-Fr,  IHC-P, In vitro, KD, KO, PAGE, Simple Western, WB
M6000B
Species: Mu
Applications: ELISA
NBP2-94448
Species: Hu, Mu, Rt
Applications: ELISA, IHC,  IHC-P, WB
DRG00
Species: Hu
Applications: ELISA
NB100-56722
Species: Ca, Hu, Mu, Rb, Rt
Applications: B/N, DB, ELISA, Flow-CS, Flow, Func, ICC/IF, IP, In vitro, WB
NBP3-16774
Species: Hu, Mu, Rt
Applications: ChIP, ELISA, ICC/IF, IHC,  IHC-P, IP, WB
DY417
Species: Mu
Applications: ELISA
AF1230
Species: Hu, Mu, Rt
Applications: IHC, KO, WB
NB100-56583
Species: Hu, Rb, Rt
Applications: Flow, IHC,  IHC-P, KO, Simple Western, WB
H00026959-P01
Species: Hu
Applications: ELISA, AP, PA, WB
NB110-41539
Species: Hu, Mu
Applications: ICC/IF, WB
NBP1-33235
Species: Hu
Applications: IHC,  IHC-P, IP, WB
DYC1825-2
Species: Hu, Mu, Rt
Applications: ELISA
NBP1-88927
Species: Hu, Mu
Applications: ICC/IF, IHC,  IHC-P, WB
NBP1-44634
Species: Bv, Hu
Applications: CyTOF-ready, Flow, IP
DCP00
Species: Hu
Applications: ELISA
H00728695-B01P
Species: Hu
Applications: ICC/IF, IP, WB
AF3667
Species: Hu, Mu
Applications: Dual ISH-IHC, ICC, IHC, Simple Western, WB
1690-HM
Species: Hu
Applications: Binding Activity

Publications for HMGB1/HMG-1 (1690-HM)(72)

We have publications tested in 8 confirmed species: Human, Mouse, Rat, Equine, Feline, Porcine, Rabbit, Transgenic Mouse.

We have publications tested in 11 applications: Binding Assay, Bioassay, Cell Culture, ELISA (Capture), ELISA (Standard), ELISA Capture, In Vivo, In vivo assay, Protein Filtration, Surface Plasmon Resonance, Western Blot.


Filter By Application
Binding Assay
(3)
Bioassay
(52)
Cell Culture
(3)
ELISA (Capture)
(1)
ELISA (Standard)
(1)
ELISA Capture
(2)
In Vivo
(8)
In vivo assay
(1)
Protein Filtration
(1)
Surface Plasmon Resonance
(1)
Western Blot
(1)
All Applications
Filter By Species
Human
(36)
Mouse
(26)
Rat
(8)
Equine
(1)
Feline
(1)
Porcine
(1)
Rabbit
(1)
Transgenic Mouse
(1)
All Species
Showing Publications 1 - 10 of 72. Show All 72 Publications.
Publications using 1690-HM Applications Species
Ge, X;Han, H;Desert, R;Das, S;Song, Z;Komakula, SSB;Chen, W;Athavale, D;Lantvit, D;Nieto, N; A PROTEIN COMPLEX OF LIVER ORIGIN ACTIVATES A PRO-INFLAMMATORY PROGRAM THAT DRIVES HEPATIC AND INTESTINAL INJURY IN ALCOHOL-ASSOCIATED LIVER DISEASE Cellular and molecular gastroenterology and hepatology 2024-05-22 [PMID: 38788899] (In vivo assay, Transgenic Mouse) In vivo assay Transgenic Mouse
SH Kim, DE Jung, JY Song, J Jung, JK Jung, H Lee, E Roh, JT Hong, SB Han, Y Kim Targeting IKKbeta Activity to Limit Sterile Inflammation in Acetaminophen-Induced Hepatotoxicity in Mice Pharmaceutics, 2023-02-20;15(2):. 2023-02-20 [PMID: 36840032] (Bioassay, Mouse) Bioassay Mouse
J Zheng, P Lan, M Li, MC Kang, M Xun, X Ma, M Yan, D Sun, Y Shen, X Fu, X Ding, X Yan, WJ Xue Anti-Na+/K+-ATPase DR antibody attenuates UUO-induced renal fibrosis through inhibition of Na+/K+-ATPase alpha1-dependent HMGB1 release International immunopharmacology, 2023-02-09;116(0):109826. 2023-02-09 [PMID: 36764269] (Bioassay, Human) Bioassay Human
S Osonoi, H Mizukami, Y Takeuchi, H Sugawa, S Ogasawara, S Takaku, T Sasaki, K Kudoh, K Ito, K Sango, R Nagai, Y Yamamoto, M Daimon, H Yamamoto, S Yagihashi RAGE activation in macrophages and development of experimental diabetic polyneuropathy JCI Insight, 2022-12-08;7(23):. 2022-12-08 [PMID: 36477360] (Cell Culture, Mouse) Cell Culture Mouse
S Takasawa, C Tsuchida, S Sakuramoto, T Uchiyama, M Makino, A Yamauchi, A Itaya-Hiro Upregulation of REG IV gene in human intestinal epithelial cells by lipopolysaccharide via downregulation of microRNA-24 Journal of Cellular and Molecular Medicine, 2022-08-09;0(0):. 2022-08-09 [PMID: 35946046] (Cell Culture, Human) Cell Culture Human
CE Roth, RB Craveiro, C Niederau, H Malyaran, S Neuss, J Jankowski, M Wolf Mechanical Compression by Simulating Orthodontic Tooth Movement in an In Vitro Model Modulates Phosphorylation of AKT and MAPKs via TLR4 in Human Periodontal Ligament Cells International Journal of Molecular Sciences, 2022-07-22;23(15):. 2022-07-22 [PMID: 35897640] (Bioassay, Human) Bioassay Human
K Amornsupak, S Thongchot, C Thinyakul, C Box, S Hedayat, P Thuwajit, SA Eccles, C Thuwajit HMGB1 mediates invasion and PD-L1 expression through RAGE-PI3K/AKT signaling pathway in MDA-MB-231 breast cancer cells BMC Cancer, 2022-05-24;22(1):578. 2022-05-24 [PMID: 35610613] (Bioassay, Human) Bioassay Human
X Bi, X Yan, B Jiang, J Liang, J Zhou, S Lu, J Liu, L Luo, Z Yin Indoprofen exerts a potent therapeutic effect against sepsis by alleviating high mobility group box 1-mediated inflammatory responses Toxicology and Applied Pharmacology, 2021-10-29;433(0):115778. 2021-10-29 [PMID: 34755645] (Bioassay, Human) Bioassay Human
S Fischer, E Nasyrov, M Brosien, KT Preissner, HH Marti, R Kunze Self-extracellular RNA promotes pro-inflammatory response of astrocytes to exogenous and endogenous danger signals Journal of Neuroinflammation, 2021-11-02;18(1):252. 2021-11-02 [PMID: 34727934] (Bioassay, Mouse) Bioassay Mouse
S Kishi, Y Nishiguchi, K Honoki, S Mori, R Fujiwara-T, T Sasaki, K Fujii, I Kawahara, K Goto, C Nakashima, A Kido, Y Tanaka, Y Luo, H Kuniyasu Role of Glycated High Mobility Group Box-1 in Gastric Cancer International Journal of Molecular Sciences, 2021-05-13;22(10):. 2021-05-13 [PMID: 34068442] (Bioassay, Human) Bioassay Human
Show All 72 Publications.

Reviews for HMGB1/HMG-1 (1690-HM) (0)

There are no reviews for HMGB1/HMG-1 (1690-HM). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen

FAQs for HMGB1/HMG-1 (1690-HM) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.

Contact Information

Product PDFs

Calculators

Concentration Calculator

The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.

=
÷

Review this Product

Be the first to review our Recombinant Human HMGB1, CF and receive a gift card or discount.

Bioinformatics

Uniprot